Terminated PHASE2 INTERVENTIONAL 2-arm NCT00830401

The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases

Comparative Controlled Trial of Treatment of Minor Unexpected Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy Screening in Women Indicated for IVF

Sponsor: AZ-VUB

Conditions Minor Intra-uterine Abnormalities

Interventions Ofloxacinum/Doxycycline Treatment of predefined abnormality by hysteroscopic surgery

Updated 5 times since 2017 Last updated: Jun 3, 2015 Started: Jun 30, 2007 Primary completion: Nov 30, 2008 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Abnormality prevalence revealed to be much lower than expected.

Other terminated trials from AZ-VUB

Islet Transplantation · Phase NA

See all terminations from AZ-VUB

A PHASE2 clinical study on Minor Intra-uterine Abnormalities, this trial is terminated or withdrawn. The trial is conducted by AZ-VUB and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AZ-VUB
UMC Utrecht

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands